🇺🇸

US SEC Filing Intelligence

· daily

Significant Contract Modifications ($10M+) — June 17, 2026

The $539.3 million in significant contract modifications from June 17, 2026, is heavily weighted toward a single civilian award: TOTE SERVICES, LLC's $309.6 million firm-fixed-price delivery order from the Maritime Administration for the NSMV V vessel, which is 85% funded and provides multi-year revenue visibility through 2029. Only one of the three contracts is defense-related (Leidos Biomedical Research's $126.4 million NIH NCI GOCO facility management award), underscoring a civilian infrastructure and life sciences R&D theme rather than a defense spending surge. The highest-conviction signal is the TOTE award, which is bullish due to its high funding outlay and stable shipbuilding demand, but carries medium execution risk from the fixed-price structure. Key risks include Kiewit Infrastructure West's $103.3 million Yosemite wastewater plant contract, which is fully obligated but high-risk due to fixed-price construction exposure, and the lack of any defense-related growth catalyst in this batch.

3 total filings
· daily

Contract Deobligations Alert — June 17, 2026

The June 17, 2026 contract deobligations digest totals $539.3 million, with 1 of 3 contracts defense-related (TOTE Services' $309.6M vessel award), reflecting a civilian-heavy mix. The highest-conviction signal is TOTE Services' fully funded firm-fixed-price delivery order for the NSMV V vessel, which provides 85% funded revenue visibility through 2029 but carries fixed-price execution risk. A key watch item is Kiewit Infrastructure West Co.'s $103.3M National Park Service wastewater treatment plant contract, which is fully obligated at award but carries high execution risk due to its fixed-price nature and long duration. The digest reveals a pattern of large, non-small businesses winning competitively awarded contracts across civilian agencies (Transportation, HHS, Interior), with no sole-source or set-aside signals, indicating a neutral-to-bullish environment for established contractors in shipbuilding, life sciences R&D, and civil infrastructure.

3 total filings
· daily

Contract Option Exercises — June 17, 2026

The June 17, 2026 contract option exercise stream totals $539.3 million in obligations, with only one-third defense-related, reflecting a civilian-heavy mix led by the Department of Transportation's Maritime Administration. The highest-conviction signal is TOTE Services' $309.6 million firm-fixed-price award for NSMV V vessel construction, which is 85% funded and provides multi-year revenue visibility but carries fixed-price execution risk through 2029. Leidos Biomedical Research's $126.4 million NIH NCI facility management contract offers stable, low-risk cost-plus revenue but has limited upside as it expires in August 2024. Kiewit Infrastructure's $103.3 million Yosemite wastewater plant contract is fully obligated but carries high execution risk due to its fixed-price structure and long duration. Key watch items include TOTE's ability to deliver on budget and potential follow-on NSMV contracts from the Maritime Administration.

3 total filings
· daily

All HHS Contracts — June 17, 2026

The sole HHS contract analyzed, a $126.4M cost-plus-fixed-fee delivery order awarded to Leidos Holdings, Inc. by the NIH National Cancer Institute, represents a stable, low-risk civilian revenue stream for the company through August 2024. The contract, won under full-and-open competition, reinforces Leidos' entrenched position in federal life sciences R&D facility management, but its fixed end date and lack of options limit upside. With $74.2M already outlayed, approximately $52.2M remains in obligated funding, providing near-term visibility. The key risk is the absence of a follow-on award or extension, which could create a revenue gap for Leidos' biomedical research segment. No defense-related contracts were identified in this period, underscoring a purely civilian healthcare R&D theme.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — June 17, 2026

The three contracts totaling $539.3 million are overwhelmingly civilian, with only one-third defense-related (the TOTE Services shipbuilding award) and the remainder split between Leidos' NIH facility management and Kiewit's National Park Service infrastructure work. The strongest investment signal is the $309.6 million TOTE Services vessel contract, which is 85% funded already and provides multi-year revenue visibility, though the firm-fixed-price structure introduces execution risk over a multi-year build. The Leidos contract is a low-risk, cost-plus R&D support award, but the 2019 award date and partial funding limit forward visibility. The Kiewit wastewater plant contract carries high fixed-price execution risk on a complex build. Key watch items include TOTE's cost performance on the NSMV V vessel and potential for follow-on Maritime Administration contracts.

3 total filings
· daily

High-Value Federal Grants ($5M+) — June 17, 2026

Over the period, $539.3 million in high-value federal grants was obligated across three distinct contracts, with only one-third defense-related, skewing the aggregate toward civilian infrastructure and life sciences. The dominant theme is stable, multi-year revenue visibility for large contractors: TOTE Services’ $309.6M shipbuilding award is the highest-conviction signal, with 85% already funded, though fixed-price execution risk persists through 2029. Leidos’ $126.4M NIH facility management contract and Kiewit’s $103.3M National Park Service project offer lower-margin, low-risk cash flows. Key risks include Kiewit’s high fixed-price construction exposure and Leidos’ contract expiration in August 2024 with no options. The digest suggests a moderate, civilian-led procurement environment with limited defense catalysts.

3 total filings
· daily

General Federal Contracts — June 17, 2026

Over a single day on June 17, 2026, three federal contracts totaling $539.3 million were awarded, with only one (the $309.6M TOTE Services vessel) being defense-related, signaling a civilian-heavy procurement day. The dominant theme is large-scale, firm-fixed-price infrastructure and construction awards to non-small businesses (TOTE, Leidos, Kiewit), which carry significant execution risk due to fixed-price transfer of cost overruns to contractors. The highest-conviction signal is the TOTE Services award, which is 85% funded ($264.2M already outlaid), reducing future payment risk but exposing TOTE to potential cost overruns on a single-vessel delivery through 2029. A key risk is the concentration of all three awards to large, non-small businesses via full-and-open competition, suggesting compressed margins and no set-aside policy tailwinds.

3 total filings
· daily

S&P 500 Technology Sector SEC Filings — June 17, 2026

The 32 filings from S&P 500 Technology companies reveal a significant wave of insider selling, particularly among semiconductor and software firms, with notable transactions from CEOs at Applied Materials, CrowdStrike, and Snowflake. Despite positive insider buying from Autodesk's CEO, the overall sentiment is bearish, with 15 negative signals versus 1 positive. Period-over-period data is limited, but the lack of forward-looking guidance or capital allocation changes suggests a focus on insider activity. Key themes include concentrated selling in semiconductors (Applied Materials), consistent insider sales at Snowflake and CrowdStrike, and routine director awards at Datadog. Investors should monitor these insider patterns as potential signals of management sentiment, while the absence of material operational or financial updates keeps the focus on equity transactions.

30 high priority 2 medium 32 total filings
· daily

Nasdaq 100 Stocks SEC Filings — June 17, 2026

The 28 filings from NASDAQ-100 constituents reveal a concentrated insider selling pattern across semiconductor and tech hardware companies, with Applied Materials executives and directors selling over $26M in stock at elevated prices, while Meta directors received routine RSU grants. Tesla's CEO Elon Musk exercised a massive option award worth $7.09B, with shares withheld for taxes, maintaining a 19.9% beneficial ownership stake. No period-over-period comparisons or forward-looking guidance were present in these filings, limiting trend analysis. The dominant theme is insider selling at or near recent highs, particularly in the semiconductor equipment sector, which may signal management caution. Capital allocation actions were absent, with no dividends, buybacks, or M&A disclosed. The digest focuses on actionable signals from insider transactions and ownership changes.

23 high priority 5 medium 28 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — June 17, 2026

This intelligence stream reveals significant activist and institutional activity centered on shareholder value maximization and corporate control. Key themes include explicit activist positioning by the Smith family at Sonic Automotive, who are openly seeking to take the company private, and Oramed Pharmaceuticals' vocal opposition to Nano Dimension's proposed transaction with Infinite Epigenetics. Major institutional staking is evident, with Vanguard increasing its Cogent Communications stake to 10.3% and Millennium Management taking 5%+ positions in WW International and TPG Inc. Notable exits include Lynrock Lake's aggressive sell-down of Teradata stock and Horizon Space Acquisition's de-SPAC exit. Related party block trades and insider monetization are observed at EchoStar (Charles Ergen's 53.2% static control) and Stablecoin Development Corp (formerly NovaBay), where major holders exercised warrants to maintain dominant >45% stakes. A significant M&A catalyst is pending with Holcim's public tender offer for Cementos Pacasmayo, while the Open Lending Corp acquisition at $3.15/share provides a clear arbitrage opportunity. The overall theme is one of capital reallocation, with passive institutional accumulation in select names offset by activist pressure and ownership consolidation in others, particularly in the technology and automotive sectors.

15 high priority 15 medium 30 total filings
· daily

S&P 500 Financials Sector SEC Filings — June 17, 2026

The S&P 500 Financials sector is showing a bifurcated picture: strong operational performance in insurance (Progressive) and exchange operators (CME Group) contrasts with mixed signals from major banks and card networks. Progressive's May results are a standout, with net income surging 36% YoY and a combined ratio improvement of 4.8 points to 82.1, signaling exceptional underwriting discipline. However, insider activity raises caution: the CEO of Bank of America disposed of $1M in stock, and a top executive at American Express sold $2.39M, while a 10% owner of Aflac continued a selling program. The most critical development is CME Group's planned CEO succession, which is orderly but marks a leadership change after 25 years of extraordinary growth (market cap up 8,000%). Capital markets activity is evident with American Express issuing €750M in senior notes, indicating opportunistic debt financing. The key portfolio-level theme is that property & casualty insurers are outperforming, while commercial lines and property lines at Progressive show flat or declining growth, signaling a potential shift in the insurance cycle.

7 high priority 1 medium 8 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — June 17, 2026

The latest batch of SEC filings from the S&P 500 Consumer Staples sector reveals a period of notable insider activity, with several high-level executives and a major 10% owner executing significant stock sales, signaling potential caution at the top. While director-level awards at Hershey are routine, the sale of nearly $1.3 million in shares by the Hershey Trust and a $997,000 sale by Church & Dwight's EVP of Technology stand out as bearish signals. Leadership transitions at Clorox and Campbell's introduce execution risk, though they may also pave the way for strategic renewal. The absence of period-over-period financial comparisons, forward guidance, or capital allocation changes in these filings limits the ability to identify broad sector trends, but the insider activity pattern suggests a divergence in management conviction across the group.

10 high priority 10 total filings
· daily

S&P 500 Industrials Sector SEC Filings — June 17, 2026

From the single enriched filing for an S&P 500 Industrials constituent, CSX Corp, the intelligence stream yields a neutral, low-materiality signal centered on director compensation. The filing reveals a routine equity award to Director J. Steven Whisler, with no concurrent period-over-period comparisons, forward-looking guidance, capital allocation changes, or earnings-related data available. This event carries negligible market impact but does highlight a stable insider holdings pattern, with the director maintaining a significant position post-transaction. Overall, the industrial sector's major themes (capital spending, infrastructure, transport demand) are not addressed by this filing, and no broader portfolio-level patterns can be inferred. The key takeaway is a passive signal of no material changes or red flags at CSX Corp for the covered period.

1 high priority 1 total filings
· daily

S&P 500 Energy Sector SEC Filings — June 17, 2026

The single filing from Kinder Morgan for June 17, 2026, reveals a minor insider sale by a VP, executed under a pre-arranged 10b5-1 plan, which limits its signaling value. With only one filing in the S&P 500 Energy stream for this period, no broader sector trends or period-over-period comparisons can be synthesized. The transaction is small in size and materiality, suggesting it is likely part of routine portfolio management rather than a reflection of deteriorating company fundamentals. Investors should view this as a low-conviction signal and focus on upcoming sector-wide earnings and operational updates for more actionable intelligence.

1 high priority 1 total filings
· daily

US Material Events SEC 8-K Filings — June 17, 2026

This Material Events Monitor digest, covering 50 filings from June 17, 2026, reveals a market dominated by significant capital structure moves and leadership transitions. A clear theme is the aggressive deployment of capital through debt amendments and equity-linked facilities, with Dorman Products, N-able, Dyne Therapeutics, and Workhorse Group all restructuring their credit, signaling both growth ambitions and, in some cases, liquidity stress. The transaction cycle is active, highlighted by Rumble Inc.'s transformative acquisition of Northern Data AG and Ziff Davis's $1.2 billion divestiture, while Simulations Plus and Avalanche Treasury Corp are in play, creating binary outcomes for shareholders. Management teams are rotating at a high velocity, with CFO changes at Innodata, Certara, and AMC Networks, and a broader wave of board restructuring at Visteon, Graham Corp, and Alaska Air Group, which often signals a shift in strategic direction. Financial health is a key differentiator: Outset Medical and Dyne Therapeutics are securing growth capital, whereas CEA Industries' financial statement restatement and NovaBay's dilutive warrant exercises highlight acute distress. The data shows a bifurcated market where companies with strong operational momentum are accelerating, while others face heightened governance and solvency risks.

50 high priority 50 total filings
· daily

Insider Trading Pulse — June 17, 2026

The June 17, 2026 insider trading digest reveals a market characterized by cautious insider selling, particularly within the technology and healthcare sectors, where several executives executed sales under Rule 10b5-1 plans. Notable selling includes ETSY's director ($3.88M) and Global-E Online's CEO ($536K), while insider buying was limited to a few opportunistic purchases, such as Gaotu Techedu's CEO ($168K) and OneMedNet's CMO ($100K). A significant cluster of director stock awards and tax-withholding transactions was observed at LivaNova PLC and Associated Banc-Corp, indicating routine compensation events rather than conviction-based trading. The overall sentiment skews negative, with 10 sell transactions versus 2 buys, suggesting management may be taking profits or reducing exposure amid uncertain market conditions. The data also highlights a lack of forward-looking guidance changes or major capital allocation shifts, pointing to a steady-state environment where insiders are not signaling strong directional conviction.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — June 17, 2026

This digest of 8 Dow Jones 30 filings reveals a period of capital management and insider activity, with no major operational or financial updates from the group. The most significant development is American Express's €750 million debt issuance at a 3.835% fixed-to-floating rate, signaling a strategic move to lock in favorable long-term financing. Insider selling patterns are notable, with a senior executive at American Express (Chief Partner Officer) selling $2.39 million in stock, while Cisco and Walmart executives executed smaller, pre-planned sales. Apple's filings were unparseable, providing no actionable data. Verizon's 8-K references an undisclosed press release, creating an information gap that warrants monitoring. Overall, the period-over-period and forward-looking data across these filings is sparse, limiting trend analysis, but the insider activity and debt issuance provide specific, actionable signals for investors focused on capital allocation and management sentiment.

4 high priority 4 medium 8 total filings
· daily

US SEC Filings Daily Market Digest — June 17, 2026

Today's 50-filing digest reveals a market bifurcated between aggressive capital deployment (debt/equity raises, M&A) and operational stress (margin compression, insider selling). Key period-over-period trends show revenue growth decoupling from profitability: JFB Construction's 32% revenue growth masked a -$5.3M net loss swing, while Oklo's $1.59B cash position came at the cost of a 187% OpEx surge. Insider activity is mixed but notable, with Global-E's CEO and President both selling under 10b5-1 plans (~$671K combined), contrasting with Gaotu Techedu's CEO buying $168K at $2.28. Forward-looking catalysts center on the July 23 Organon/Sun Pharma special meeting (10/10 materiality) and VisionWave's data center JV (subject to Nasdaq approval). Sector themes highlight a 'growth-at-all-costs' dynamic in tech/energy, while financials show disciplined capital allocation (VEON's 92% debt tender success). The most critical development is the 50.01% Holcim tender offer for Cementos Pacasmayo, signaling potential full acquisition and sector consolidation.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — June 17, 2026

The 12 filings reveal a concentrated insider trading day across eBay’s executive suite, with at least six C-suite officers collectively surrendering ~$2.9M in shares via tax withholding exercises, signaling routine compensation cycles rather than material bearish conviction. The dominant narrative is Tesla’s massive insider activity: CEO Elon Musk exercised 303.96M options and surrendered 17.53M shares (~$7.09B) for tax withholding, holding 710M shares post-transaction—a high-certainty signal of active option monetization ahead of a potentially dilutive exercise period. Meanwhile, Chipotle’s annual meeting displayed notable shareholder dissent (47.6M against votes on say-on-pay, 27.3M against one director), pointing to governance friction at a high-multiple consumer staple. Lowe’s EVP of HR executed a clean sale of $3.14M in stock—an outlier insider disposition that warrants monitoring. Across the stream, no phase-1 period-over-period revenue, margin, or forward-looking guidance data is present; the dominant intelligence yield comes from insider-trading patterns, a scheduled governance vote, and a materiality-heavy Tesla ownership event. Investors should watch for secondary selling at eBay, board activism signals at Chipotle, and any further Tesla Form 4s as Musk unwinds option positions. All 12 filings fall squarely within the Consumer Discretionary scope, so none are excluded.

10 high priority 2 medium 12 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — June 17, 2026

This digest covers four S&P 500 Healthcare filings, revealing a sector-wide pattern of insider selling at moderate levels, a shareholder governance pushback at a major biotech, and a lack of operational or forward-looking catalysts. The three insider trading filings (Moderna, Vertex, Edwards Lifesciences) all show pre-planned, rule 10b5-1 sales by senior executives, indicating a lack of bullish conviction but not necessarily panic. The most significant event is the mixed shareholder sentiment at Regeneron's AGM, where two directors and the executive compensation package received notable against votes, signaling governance risk. No period-over-period revenue or margin trends were reported in these filings, and no forward-looking guidance or capital allocation changes were disclosed, limiting the depth of trend analysis. The overall picture is one of a mature sector with steady, but not aggressive, insider profit-taking and increasing shareholder scrutiny on pay and board composition.

4 high priority 4 total filings